|
DE3933850A1
(de)
|
1989-10-06 |
1991-04-18 |
Schering Ag |
Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins
|
|
DE122009000074I1
(de)
|
1993-03-05 |
2011-12-01 |
Bayer Healthcare Ag |
Humane monoklonale anti-TNF alpha Antikorper.
|
|
US5595756A
(en)
*
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US6383808B1
(en)
|
2000-09-11 |
2002-05-07 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of clusterin expression
|
|
US6818749B1
(en)
|
1998-10-31 |
2004-11-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Variants of humanized anti carcinoma monoclonal antibody cc49
|
|
US6464975B2
(en)
|
1998-12-11 |
2002-10-15 |
The Research Foundation Of State University Of New York |
Compositions and methods for altering cell migration
|
|
KR100820266B1
(ko)
|
1999-02-26 |
2008-04-08 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
테스토스테론이 억제된 전립선 메시지-2의 안티센스치료방법
|
|
US6900187B2
(en)
|
1999-02-26 |
2005-05-31 |
The University Of British Columbia |
TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
|
|
MXPA01010891A
(es)
|
1999-04-28 |
2002-11-07 |
Univ Texas |
Composiciones y metodos para el tratamiento contra el cancer mediante la inhibicion selectiva del factor de crecimiento endotelial vascular (vegf).
|
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
|
US20050208558A1
(en)
|
1999-10-19 |
2005-09-22 |
Applera Corporation |
Detection kits, such as nucleic acid arrays, for detecting the expression or 10,000 or more Drosophila genes and uses thereof
|
|
US7569551B2
(en)
|
2000-02-25 |
2009-08-04 |
The University Of British Columbia |
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
|
|
AU2001245280A1
(en)
|
2000-03-07 |
2001-09-17 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
US7279294B2
(en)
|
2000-04-03 |
2007-10-09 |
The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services, Nih |
Tumor markers in ovarian cancer
|
|
US6812339B1
(en)
|
2000-09-08 |
2004-11-02 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
JP2004521627A
(ja)
|
2001-02-09 |
2004-07-22 |
インサイト・ゲノミックス・インコーポレイテッド |
細胞増殖、細胞分化および細胞死に関連するタンパク質
|
|
CA2443644A1
(en)
|
2001-04-04 |
2003-01-16 |
Elan Corporation, Plc |
Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors
|
|
JP2005538706A
(ja)
|
2001-07-12 |
2005-12-22 |
ジェファーソン フーテ， |
スーパーヒト化抗体
|
|
US20030134301A1
(en)
|
2001-07-27 |
2003-07-17 |
Brooksbank Robert Alan |
Identification and use of molecules implicated in pain
|
|
WO2003016475A2
(en)
|
2001-08-14 |
2003-02-27 |
The General Hospital Corporation |
Nucleic acid and amino acid sequences involved in pain
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
WO2003054152A2
(en)
|
2001-12-10 |
2003-07-03 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
KR101166214B1
(ko)
|
2002-01-17 |
2012-07-16 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아이지에프비피-2 및 아이지에프비피-5를 억제하는 양특이성 안티센스 올리고뉴클레오티드 및 그 사용방법
|
|
EP1487857A4
(en)
|
2002-03-07 |
2006-08-09 |
Ludwig Inst Cancer Res |
BLOOD AND LYMPHATIC ENDOTHELIAL CELL GENES
|
|
WO2003080672A1
(en)
|
2002-03-22 |
2003-10-02 |
Aprogen, Inc. |
Humanized antibody and process for preparing same
|
|
AU2003281287A1
(en)
|
2002-07-04 |
2004-01-23 |
Oxford Glycosciences (Uk) Ltd |
Toxicity markers
|
|
CA2882443C
(en)
|
2002-08-21 |
2016-12-13 |
The University Of British Columbia |
Rnai probes targeting cancer-related proteins
|
|
DE60333839D1
(de)
|
2002-08-21 |
2010-09-30 |
Univ British Columbia |
Behandlung von melanomen durch reduktion der clusterin menge
|
|
CA2499843A1
(en)
|
2002-09-25 |
2004-04-08 |
Genentech, Inc. |
Novel compositions and methods for the treatment of psoriasis
|
|
US20050048490A1
(en)
|
2002-09-26 |
2005-03-03 |
Incyte Corp. |
Proteins associated with cell growth, differentiation, and death
|
|
US20070224201A1
(en)
|
2002-10-02 |
2007-09-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US8722872B2
(en)
|
2002-10-02 |
2014-05-13 |
The University Of British Columbia |
Compositions and methods for treatment of prostate and other cancers
|
|
DE10256900A1
(de)
|
2002-11-29 |
2004-06-24 |
Nemod Immuntherapie Ag |
Tumorspezifische Erkennungsmoleküle
|
|
EP1603514A4
(en)
|
2003-01-24 |
2007-08-22 |
Bayer Pharmaceuticals Corp |
EXPRESSION PROFILES FOR THYROID CANCER AND APPLICATION METHOD
|
|
WO2005049806A2
(en)
|
2003-03-14 |
2005-06-02 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
JP2006523199A
(ja)
|
2003-03-28 |
2006-10-12 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
末梢神経疾患の治療及び／又は予防のためのクラステリンの使用
|
|
US20050255114A1
(en)
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
|
US20040220131A1
(en)
|
2003-04-18 |
2004-11-04 |
The University Of British Columbia |
Method for treatment of cancerous angiogenic disorders
|
|
JP2007523839A
(ja)
|
2003-04-18 |
2007-08-23 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
血管新生性障害の治療法
|
|
WO2004111273A2
(en)
*
|
2003-05-30 |
2004-12-23 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
|
WO2005014849A2
(en)
|
2003-07-03 |
2005-02-17 |
Euro-Celtique, S.A. |
Genes associated with responses to neuropathic pain
|
|
JP2007507204A
(ja)
|
2003-07-29 |
2007-03-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
サイクリン依存性キナーゼモデュレーションのバイオマーカー
|
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
WO2005026209A2
(en)
|
2003-09-11 |
2005-03-24 |
Critical Therapeutics, Inc. |
Monoclonal antibodies against hmgb1
|
|
AT412785B
(de)
|
2003-12-04 |
2005-07-25 |
Kungl Andreas J Dr |
Gag-bindungsproteine
|
|
EP1708961B1
(en)
|
2003-12-04 |
2011-03-09 |
Abbott Biotherapeutics Corp. |
Anti-ip-10 antibodies
|
|
GB0329254D0
(en)
|
2003-12-17 |
2004-01-21 |
Univ Manchester |
Treatment of viral infections
|
|
GB0329958D0
(en)
|
2003-12-24 |
2004-01-28 |
Univ Manchester |
Treatment of viral infections
|
|
WO2005071059A2
(en)
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
|
|
US7309487B2
(en)
|
2004-02-09 |
2007-12-18 |
George Inana |
Methods and compositions for detecting and treating retinal diseases
|
|
AU2005211890B2
(en)
*
|
2004-02-12 |
2011-07-28 |
Merck Patent Gmbh |
Highly concentrated liquid formulations of anti-EGFR antibodies
|
|
ITRM20040098A1
(it)
|
2004-02-25 |
2004-05-25 |
Univ Roma |
Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.
|
|
WO2005094899A1
(en)
|
2004-04-02 |
2005-10-13 |
The University Of British Columbia |
Clusterin antisense therapy for treatment of cancer
|
|
KR20070049637A
(ko)
|
2004-07-09 |
2007-05-11 |
트리패스 이미징, 인코포레이티드 |
난소 질환 검출 방법 및 조성물
|
|
GB0421639D0
(en)
|
2004-09-29 |
2004-10-27 |
Proteome Sciences Plc |
Methods and compositions relating to alzheimer's disease
|
|
WO2006037604A1
(en)
|
2004-10-01 |
2006-04-13 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel antibodies directed to the mammalian eag1 ion channel protein
|
|
US20080014198A1
(en)
|
2004-11-23 |
2008-01-17 |
The University Of British Columbia |
Treatment of Cancer With a Combination of an Agent that Perturbs the EGF Signaling Pathway and an Oligonucleotide that Reduces Clusterin Levels
|
|
JP2008528033A
(ja)
|
2005-01-27 |
2008-07-31 |
ファイブ プライム セラピューティクス， インコーポレイテッド |
ポリペプチドの分泌を検出するためのリーダー配列およびその産生のための方法
|
|
US7883858B2
(en)
|
2005-01-27 |
2011-02-08 |
Institute For Systems Biology |
Methods for identifying and monitoring drug side effects
|
|
WO2006089586A1
(en)
|
2005-02-23 |
2006-08-31 |
Medizinische Universität Graz |
Use of a compound with clusterin activity for the treatment of diseases associated with the deposition of abnormal proteins
|
|
US7678371B2
(en)
|
2005-03-04 |
2010-03-16 |
Biogen Idec Ma Inc. |
Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
|
|
US20080307537A1
(en)
|
2005-03-31 |
2008-12-11 |
Dana-Farber Cancer Institute, Inc. |
Compositions and Methods for the Identification, Assessment, Prevention, and Therapy of Neurological Diseases, Disorders and Conditions
|
|
US20100035970A1
(en)
|
2005-04-15 |
2010-02-11 |
Oncomethylome Sciences, S.A. |
Methylation Markers for Diagnosis and Treatment of Cancers
|
|
WO2007022248A2
(en)
|
2005-08-16 |
2007-02-22 |
Sloan Kettering Institute For Cancer Research |
Methods of detection of cancer using peptide profiles
|
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
ES2543341T3
(es)
|
2005-09-13 |
2015-08-18 |
National Research Council Of Canada |
Métodos y composiciones para modular la actividad de células tumorales
|
|
AU2006304804B2
(en)
|
2005-10-21 |
2011-06-02 |
Vertex Pharmaceuticals Incorporated |
Modified proteases that inhibit complement activation
|
|
US7972802B2
(en)
|
2005-10-31 |
2011-07-05 |
University Of Washington |
Lipoprotein-associated markers for cardiovascular disease
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
US20090181380A1
(en)
|
2005-12-19 |
2009-07-16 |
Abdelmajid Belouchi |
Genemap of the human genes associated with crohn's disease
|
|
CA2634072A1
(en)
|
2005-12-21 |
2007-06-28 |
Universite De Montreal |
Markers for memory t cells and uses thereof
|
|
KR100679173B1
(ko)
|
2006-02-28 |
2007-02-06 |
주식회사 바이오인프라 |
위암 진단용 단백질 마커 및 이를 이용한 진단키트
|
|
RS51723B2
(sr)
|
2006-03-23 |
2018-03-30 |
Bioarctic Neuroscience Ab |
Poboljšana antitela selektivna za protofibrile i njihova primena
|
|
US20080026485A1
(en)
|
2006-04-18 |
2008-01-31 |
Wolfgang Hueber |
Antibody profiling for determination of patient responsiveness
|
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
EP2087152B1
(en)
|
2006-10-27 |
2015-03-11 |
Walfish, Paul |
Endometrial biomarkers
|
|
WO2008085024A1
(en)
|
2007-01-12 |
2008-07-17 |
Erasmus University Medical Center Rotterdam |
Identification and detection of peptides relating to specific disorders
|
|
GB0703652D0
(en)
|
2007-02-26 |
2007-04-04 |
Univ Bradford |
Method for the allosteric modulation of beta1 integrin
|
|
US8568993B2
(en)
|
2007-07-02 |
2013-10-29 |
Purdue Research Foundation |
Detection of glycopeptides and glycoproteins for medical diagnostics
|
|
WO2009034562A2
(en)
|
2007-09-11 |
2009-03-19 |
Dublin City University |
A method of assessing lung squamous cell carcinoma status in an individual
|
|
WO2009061382A2
(en)
|
2007-11-02 |
2009-05-14 |
Marban Eduardo T |
Cardiac stem cell and myocyte secreted paracrine factors and uses thereof
|
|
US7923253B2
(en)
|
2007-11-05 |
2011-04-12 |
Battelle Memorial Institute |
Method for identifying type I diabetes mellitus in humans
|
|
EP2071336A1
(en)
|
2007-12-13 |
2009-06-17 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Serum proteomic for finding diagnostic markers and for monitoring therapeutical intervention in treatment of hepatocellular carcinoma
|
|
WO2009117030A2
(en)
|
2007-12-19 |
2009-09-24 |
Macrogenics, Inc. |
Improved compositions for the prevention and treatment of smallpox
|
|
EP2080812A1
(en)
|
2008-01-18 |
2009-07-22 |
Transmedi SA |
Compositions and methods of detecting post-stop peptides
|
|
EP2240196A2
(en)
|
2008-01-22 |
2010-10-20 |
Compugen Ltd. |
Clusterin derived peptide
|
|
WO2009116860A1
(en)
|
2008-03-17 |
2009-09-24 |
Vereniging Het Nederlands Kanker Instituut |
Markers providing prognosis of metastasis among cancer patients
|
|
KR101110758B1
(ko)
|
2008-06-02 |
2012-02-15 |
경북대학교 산학협력단 |
뇌졸중 표적용 펩티드 및 이의 용도
|
|
US8148088B2
(en)
|
2008-07-18 |
2012-04-03 |
Abgent |
Regulation of autophagy pathway phosphorylation and uses thereof
|
|
WO2010030980A2
(en)
|
2008-09-12 |
2010-03-18 |
University Of South Florida |
Akt and clusterin as biomarkers of chemotherapeutic responsiveness
|
|
WO2010118521A1
(en)
|
2009-04-17 |
2010-10-21 |
National Research Council Of Canada |
Peptide ligands for clusterin and uses thereof
|
|
HRP20191129T1
(hr)
*
|
2009-11-24 |
2019-09-20 |
Alethia Biotherapeutics Inc. |
Anti-klusterinska protutijela i ulomci koji vežu antigen i njihova uporaba za smanjivanje volumena tumora
|
|
EA201491568A1
(ru)
|
2012-02-22 |
2014-11-28 |
Алетиа Байотерапьютикс Инк. |
Совместное применение ингибитора кластерина и ингибитора egfr для лечения рака
|